1,728 results on '"Chen, Zhe-Sheng"'
Search Results
202. Supplementary Figure Legends 1-3 from Apatinib (YN968D1) Reverses Multidrug Resistance by Inhibiting the Efflux Function of Multiple ATP-Binding Cassette Transporters
203. Supplementary Figure 1 from Human Multidrug Resistance Protein 7 (ABCC10) Is a Resistance Factor for Nucleoside Analogues and Epothilone B
204. Supplementary Figure 2 from Apatinib (YN968D1) Reverses Multidrug Resistance by Inhibiting the Efflux Function of Multiple ATP-Binding Cassette Transporters
205. Supplementary Table 1 from Sildenafil Reverses ABCB1- and ABCG2-Mediated Chemotherapeutic Drug Resistance
206. Supplementary Figures 1-2 from Lapatinib (Tykerb, GW572016) Reverses Multidrug Resistance in Cancer Cells by Inhibiting the Activity of ATP-Binding Cassette Subfamily B Member 1 and G Member 2
207. Supplementary Figure Legend from Contribution of Abcc10 (Mrp7) to In Vivo Paclitaxel Resistance as Assessed in Abcc10−/− Mice
208. The Battlefield of Chemotherapy in Pediatric Cancers
209. MYH10 Combines with MYH9 to Recruit USP45 by Deubiquitinating Snail and Promotes Serous Ovarian Cancer Carcinogenesis, Progression, and Cisplatin Resistance
210. Multiple Components in Chinese Medicine formula for Drug Discovery: State-of-art and future perspective
211. Progress in the studies on the molecular mechanisms associated with multidrug resistance in cancers
212. Discovery of Norbornene as a Novel Hydrophobic Tag Applied in Protein Degradation
213. Preface
214. Design, Synthesis and Biological Evaluation of Quinazolinamine Derivatives as Breast Cancer Resistance Protein and P-Glycoprotein Inhibitors with Improved Metabolic Stability
215. Editorial: Novel biomarkers for anticancer therapy
216. Tumor Microenvironment and Cancer Therapy
217. Novel biomarkers for anticancer therapy
218. Multi-component Chinese medicine formulas for drug discovery: State of the art and future perspectives
219. Synthesis and evaluation of WK-X-34 derivatives as P-glycoprotein (P-gp/ABCB1) inhibitors for reversing multidrug resistance
220. Role of Gut Microbiota in Diabetes Mellitus and Tumor Immunity
221. Overcoming ABC transporter-mediated multidrug resistance: Molecular mechanisms and novel therapeutic drug strategies
222. Cytokines in cancer drug resistance: Cues to new therapeutic strategies
223. Exploring naturally occurring ivy nanoparticles as an alternative biomaterial
224. Silver nanoparticles: synthesis, properties, and therapeutic applications
225. The modulation of ABC transporter-mediated multidrug resistance in cancer: A review of the past decade
226. Functions and therapeutic potentials of exosomes in osteosarcoma
227. Palmitoyl Carnitine-Anchored Nanoliposomes for Neovasculature-Specific Delivery of Gemcitabine Elaidate to Treat Pancreatic Cancer
228. The Single‐Cell Landscape of Intratumoral Heterogeneity and The Immunosuppressive Microenvironment in Liver and Brain Metastases of Breast Cancer
229. An Impact of COVID-19 on Cancer Care: An Update
230. Stellettin B Sensitizes Glioblastoma to DNA‐Damaging Treatments by Suppressing PI3K‐Mediated Homologous Recombination Repair
231. DNA damage repair gene mutations predict the efficacy of platinum-based chemotherapy and immunotherapy plus platinum-based chemotherapy in advanced non-small cell lung cancer: a retrospective Chinese cohort study
232. Isolation, bioassay and 3D-QSAR analysis of 8-isopentenyl flavonoids from Epimedium sagittatum Maxim. as PDE5A inhibitors
233. Role of protein phosphorylation in cell signaling, disease, and the intervention therapy
234. Editorial: Medicinal plants in the treatment of gastrointestinal cancers: How can OMICS and other advanced approaches help in understanding their mechanisms of action?
235. Inhibiting the Activity of ABCG2 by KU55933 in Colorectal Cancer
236. Prognostic and Therapeutic Values of Autophagy-related Genes in Triple-negative Breast Cancer
237. Successes and failures of immunotherapy for gastric cancer
238. The effect and mechanistic study of encequidar on reversing the resistance of SW620/AD300 cells to doxorubicin
239. Extracellular Vesicles in Cancer Drug Resistance: Roles, Mechanisms, and Implications
240. Advances in stromal cell therapy for management of Alzheimer’s disease
241. Fast-track development of vaccines for SARS-CoV-2: The shots that saved the world
242. Synthesis and evaluation of sulfonylethyl-containing phosphotriesters of 3′-azido-3′-deoxythymidine as anticancer prodrugs
243. Jiyuan oridonin A induces differentiation of acute myeloid leukemia cells including leukemic stem-like cells
244. COVID-19 and vaccination: myths vs science
245. Histone Deacetylase Inhibitor I3 Induces the Differentiation of Acute Myeloid Leukemia Cells with t (8; 21) or MLL Gene Translocation and Leukemic Stem-Like Cells
246. Palmitic Acid Impedes Extravillous Trophoblast Activity by Increasing MRP1 Expression and Function
247. Anticancer effect of Indanone-based thiazolyl hydrazone derivative on p53 mutant colorectal cancer cell lines: An in vitro and in vivo study
248. Discovery of a Novel Vascular Disrupting Agent Inhibiting Tubulin Polymerization and HDACs with Potent Antitumor Effects
249. Preclinical studies of the triazolo[1,5-a]pyrimidine derivative WS-716 as a highly potent, specific and orally active P-glycoprotein (P-gp) inhibitor
250. Zandelisib. Phosphatidylinositol 3-kinase δ (PI3Kδ) inhibitor, Treatment of B-cell lymphomas
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.